These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23963599)

  • 1. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.
    Phillips LM; Hachamovitch R; Berman DS; Iskandrian AE; Min JK; Picard MH; Kwong RY; Friedrich MG; Scherrer-Crosbie M; Hayes SW; Sharir T; Gosselin G; Mazzanti M; Senior R; Beanlands R; Smanio P; Goyal A; Al-Mallah M; Reynolds H; Stone GW; Maron DJ; Shaw LJ
    J Nucl Cardiol; 2013 Dec; 20(6):969-75. PubMed ID: 23963599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?
    Xie JX; Winchester DE; Phillips LM; Hachamovitch R; Berman DS; Blankstein R; Di Carli MF; Miller TD; Al-Mallah MH; Shaw LJ
    J Nucl Cardiol; 2017 Oct; 24(5):1610-1618. PubMed ID: 28752313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications and Debates on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches Trial.
    Saito Y; Nishi T; Saito K; Kitahara H; Kawase Y; Matsuo H; Kobayashi Y
    Cardiol Rev; 2022 Sep-Oct 01; 30(5):234-240. PubMed ID: 33758121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials.
    Torosoff MT; Sidhu MS; Boden WE
    Herz; 2013 Jun; 38(4):382-6. PubMed ID: 23695652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges with Evidence-Based Management of Stable Ischemic Heart Disease.
    Patel AV; Bangalore S
    Curr Cardiol Rep; 2017 Feb; 19(2):11. PubMed ID: 28185167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of coronary revascularization after myocardial perfusion SPECT: The role of ischemia.
    Sharir T; Hollander I; Hemo B; Tsamir J; Yefremov N; Bojko A; Prokhorov V; Pinskiy M; Slomka P; Amos K
    J Nucl Cardiol; 2021 Aug; 28(4):1676-1687. PubMed ID: 31823328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Weintraub WS; Mancini GBJ; Boden WE
    Int J Cardiol; 2023 Feb; 373():39-43. PubMed ID: 36427605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ; Novak E; Brown DL
    Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia.
    Gada H; Kirtane AJ; Kereiakes DJ; Bangalore S; Moses JW; Généreux P; Mehran R; Dangas GD; Leon MB; Stone GW
    Am J Cardiol; 2015 May; 115(9):1194-9. PubMed ID: 25759103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How and when to decide on revascularization in stable ischemic heart disease.
    Mecklai A; Bangalore S; Hochman J
    Curr Treat Options Cardiovasc Med; 2013 Feb; 15(1):79-92. PubMed ID: 23143818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.
    Taqueti VR; Dorbala S; Wolinsky D; Abbott B; Heller GV; Bateman TM; Mieres JH; Phillips LM; Wenger NK; Shaw LJ
    J Nucl Cardiol; 2017 Aug; 24(4):1402-1426. PubMed ID: 28585034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions.
    Bangalore S; Gupta N; Généreux P; Guo Y; Pancholy S; Feit F
    Int J Cardiol; 2015 Mar; 183():6-10. PubMed ID: 25662046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease.
    Ujueta F; Weiss EN; Shah B; Sedlis SP
    Curr Cardiol Rep; 2017 Feb; 19(2):17. PubMed ID: 28213668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ischemia and scar on therapeutic benefit of myocardial revascularization.
    Hachamovitch R
    Herz; 2013 Jun; 38(4):344-9. PubMed ID: 23625299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.